Listed

Chemed Corp

CHENYSECIK 19584HealthcareFiscal year ends Dec 31

Latest reported revenue, Q3 FY2026$690.9mRevenue, Q3 FY2026, three months to 2026-09-30$690.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 29, 2026.

Latest quarter: Q3 FY2026

Three months to Sep 30, 2026, against the same quarter a year earlier.

  • Revenue$690.9mRevenue, Q3 FY2026, three months to 2026-09-30$690.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure+10.6% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin14.0%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $96.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Revenue: $690.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure+2.0 pts on a year earlier
  • Net margin10.4%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $71.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Revenue: $690.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure+0.1 pts on a year earlier
  • Diluted EPS$5.45Diluted EPS, Q3 FY2026, three months to 2026-09-30$5.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure+22.2% on a year earlier
  • Free cash flow$37.9mFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $56.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0000019584-26-000024. Derived: 9-month figure less the 6-month figure.Capital expenditure: $18.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0000019584-26-000024. Derived: 9-month figure less the 6-month figure.Report this figure−42.5% on a year earlier

Last eight quarters

Full statements
Revenue$690.9mOperating margin 14.0%
Diluted EPS$5.45, Q3 FY2026
Free cash flow$37.9m, Q3 FY2026
Chemed Corp, key figures for the last eight quarters
Line itemUnitQ4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30Shape over the periods
Revenue$m411Revenue, Q4 FY2024, three months to 2024-12-31$411.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038. Derived: 12-month figure less the 9-month figure.Report this figure647Revenue, Q1 FY2025, three months to 2025-03-31$646.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure619Revenue, Q2 FY2025, three months to 2025-06-30$618.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Report this figure625Revenue, Q3 FY2025, three months to 2025-09-30$624.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure639Revenue, Q4 FY2025, three months to 2025-12-31$639.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure658Revenue, Q1 FY2026, three months to 2026-03-31$657.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure673Revenue, Q2 FY2026, three months to 2026-06-30$673.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Report this figure691Revenue, Q3 FY2026, three months to 2026-09-30$690.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%27.7%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $113.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Revenue: $411.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038. Derived: 12-month figure less the 9-month figure.Report this figure14.6%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $94.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Revenue: $646.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure11.0%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $68.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Revenue: $618.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Report this figure12.0%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $74.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Revenue: $624.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure15.7%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $100.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Revenue: $639.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure12.9%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $84.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Revenue: $657.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure13.2%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $89.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Revenue: $673.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Report this figure14.0%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $96.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Revenue: $690.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure
Net margin%22.0%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $90.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Revenue: $411.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038. Derived: 12-month figure less the 9-month figure.Report this figure11.1%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $71.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Revenue: $646.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure8.5%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $52.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Revenue: $618.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Report this figure10.3%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $64.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Revenue: $624.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure12.0%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $76.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Revenue: $639.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure10.1%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $66.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Revenue: $657.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure10.1%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $67.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Revenue: $673.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Report this figure10.4%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $71.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Revenue: $690.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)4.86Diluted EPS, Q1 FY2025, three months to 2025-03-31$4.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure3.57Diluted EPS, Q2 FY2025, three months to 2025-06-30$3.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Report this figure4.46Diluted EPS, Q3 FY2025, three months to 2025-09-30$4.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figurenot reported (Diluted EPS not reported)4.84Diluted EPS, Q1 FY2026, three months to 2026-03-31$4.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure5.13Diluted EPS, Q2 FY2026, three months to 2026-06-30$5.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0000019584-26-000020.Report this figure5.45Diluted EPS, Q3 FY2026, three months to 2026-09-30$5.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000019584-26-000024.Report this figure
Free cash flow$m152Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $164.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Capital expenditure: $12.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure19.5Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $32.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Capital expenditure: $13.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure123Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $138.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0000019584-26-000020. Derived: 6-month figure less the 3-month figure.Capital expenditure: $15.8m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-07-31, accession 0001562762-25-000186.Report this figure65.9Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $83.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0000019584-26-000024. Derived: 9-month figure less the 6-month figure.Capital expenditure: $17.5m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-10-31, accession 0000019584-25-000006.Report this figure117Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $133.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Capital expenditure: $16.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001562762-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure71.1Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $88.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Capital expenditure: $17.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-28, accession 0000019584-26-000012.Report this figure69.3Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $84.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0000019584-26-000020. Derived: 6-month figure less the 3-month figure.Capital expenditure: $15.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0000019584-26-000020. Derived: 6-month figure less the 3-month figure.Report this figure37.9Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $56.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0000019584-26-000024. Derived: 9-month figure less the 6-month figure.Capital expenditure: $18.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0000019584-26-000024. Derived: 9-month figure less the 6-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$2.53bnOperating margin 13.4%
Diluted EPS$18.34, FY2025
Free cash flow$325.5m, FY2025
Chemed Corp, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,261Revenue, FY2021, twelve months to 2021-12-31$1.26bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001562762-24-000045.Report this figure1,202Revenue, FY2022, twelve months to 2022-12-31$1.20bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure1,315Revenue, FY2023, twelve months to 2023-12-31$1.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure1,531Revenue, FY2024, twelve months to 2024-12-31$1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure2,530Revenue, FY2025, twelve months to 2025-12-31$2.53bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%27.2%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $343.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-29, accession 0001562762-24-000045.Revenue: $1.26bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001562762-24-000045.Report this figure28.6%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $343.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-28, accession 0001562762-25-000038.Revenue: $1.20bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure25.9%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $340.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020.Revenue: $1.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure23.9%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $366.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020.Revenue: $1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure13.4%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $338.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020.Revenue: $2.53bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure
Net margin%21.3%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $268.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-29, accession 0001562762-24-000045.Revenue: $1.26bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001562762-24-000045.Report this figure20.8%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $249.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001562762-25-000038.Revenue: $1.20bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure20.7%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $272.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020.Revenue: $1.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure19.7%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $302.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020.Revenue: $1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure10.5%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $265.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001562762-26-000020.Revenue: $2.53bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure
Diluted EPS$ per share16.85Diluted EPS, FY2021, twelve months to 2021-12-31$16.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-29, accession 0001562762-24-000045.Report this figure16.53Diluted EPS, FY2022, twelve months to 2022-12-31$16.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure17.93Diluted EPS, FY2023, twelve months to 2023-12-31$17.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure19.89Diluted EPS, FY2024, twelve months to 2024-12-31$19.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure18.34Diluted EPS, FY2025, twelve months to 2025-12-31$18.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure
Free cash flow$m250Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $308.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-29, accession 0001562762-24-000045.Capital expenditure: $58.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-29, accession 0001562762-24-000045.Report this figure253Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $309.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-28, accession 0001562762-25-000038.Capital expenditure: $57.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-28, accession 0001562762-25-000038.Report this figure273Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $330.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001562762-26-000020.Capital expenditure: $56.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure368Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $417.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001562762-26-000020.Capital expenditure: $49.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure325Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $388.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001562762-26-000020.Capital expenditure: $62.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001562762-26-000020.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Chemed Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$691.3m1,484,282Added+147,592
AQR CAPITAL MANAGEMENT LLC2026-06-30$446.2m972,474Added+556,862
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$366.6m787,068Reduced−28,631
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$281.5m604,420Reduced−31,650
STATE STREET CORP2026-06-30$207.1m444,716Reduced−17,454
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$192.8m413,942Added+2,896
JPMORGAN CHASE & CO2026-06-30$185.8m403,395Reduced−97,592
Boston Partners2026-06-30$130.7m280,684New+280,684
Epoch Investment Partners, Inc.2026-06-30$124.5m267,290Added+17,167
DIMENSIONAL FUND ADVISORS LP2026-06-30$121.3m260,561Added+12,711

Recent filings

All 1,327 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Chemed Corp, recent filings
FiledFormWhat it isAccession number
2026-10-2909:00 ET10-QQuarterly reportPeriod 2026-09-300000019584-26-000024
2026-10-2716:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000019584-26-000022
2026-07-3109:04 ET10-QQuarterly reportPeriod 2026-06-300000019584-26-000020
2026-07-2816:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000019584-26-000018
2026-05-1910:43 ET8-K5.07 Shareholder vote results0000019584-26-000014
2026-04-2809:00 ET10-QQuarterly reportPeriod 2026-03-310000019584-26-000012
2026-04-2316:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000019584-26-000010
2026-04-1309:03 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000019584-26-000008
2026-04-0609:00 ETDEF 14AProxy statementPeriod 2025-12-310000019584-26-000005
2026-02-2709:36 ET10-KAnnual reportPeriod 2025-12-310001562762-26-000020

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 27, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures.See the target

About the filer

CIK
19584
Tickers
CHE
Exchange
NYSE
SIC code
8082 Services-Home Health Care Services
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
ROTO-ROOTER INC (to 2004-06-16)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.